Search Results

A recent study in GLP-1 drugs potentially improved surgical complications and recovery in diabetes patients (Representational Image: Pexels)
Dr. Disha Merlyn Mathias
3 min read
A possibility for improving surgical complications in diabetic patients
Bariatric surgery found to be more effective than GLP-1 drugs in reducing kidney disease progression, according to a recent study. (Representational image: Wikimedia Commons)
Ankur Deka
3 min read
Study finds bariatric surgery significantly reduces risk of chronic kidney disease progression compared to GLP-1 drugs in patients with obesity and diabetes
After extensive review, the MHRA concludes no link between popular diabetes drugs like Wegovy and mental health concerns. (Wikimedia Commons)
Ankur Deka
2 min read
MHRA concludes there is no evidence to support a connection between GLP-1 receptor agonists, including Novo Nordisk's Wegovy, and suicide-related risks
Several GLP-1 receptor agonists are available on the market, including exenatide (Byetta), liraglutide (Victoza), dulaglutide (Trulicity), and semaglutide (Ozempic). (Representational Image: Unsplash)
MBT Desk
4 min read
Explore the side effects of GLP-1 drugs, used for managing type 2 diabetes, including gastrointestinal issues, hypoglycemia, pancreatitis, and more
With the skyrocketing popularity of weight-loss drugs like Ozempic, Wegovy, and Mounjaro, health experts are noticing an increasing trend of use among younger Americans. 
(Representational Image: Pixabay)
MBT Desk
3 min read
Parents Should be more Careful : Insights from Doctors on Youthful Usage of these Drugs and Health Risks
An image of Page Campbell in an orange robe sitting on a hospital bed.
MBT Desk
6 min read
Many gained access to GLP-1s through Medicaid’s decision in late 2024 to cover these weight loss drugs. But these medications remain out of reach for millions of patients across the US.
Read More
logo
Medbound
www.medboundtimes.com